The Gut Microbiota, Intestinal Permeability, Bacterial Translocation, and Nonalcoholic Fatty Liver Disease: What Comes First?
作者信息
Spengler Erin, Loomba Rohit
机构信息
Division of Gastroenterology, Department of Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
NAFLD Translational Research Unit, University of California-San Diego, La Jolla, California.
出版信息
Cell Mol Gastroenterol Hepatol. 2015 Jan 31;1(2):129-130. doi: 10.1016/j.jcmgh.2015.01.007. eCollection 2015 Mar.
Abstract
摘要
相似文献
1
The Gut Microbiota, Intestinal Permeability, Bacterial Translocation, and Nonalcoholic Fatty Liver Disease: What Comes First?肠道微生物群、肠道通透性、细菌易位与非酒精性脂肪性肝病：何者为先？
Cell Mol Gastroenterol Hepatol. 2015 Jan 31;1(2):129-130. doi: 10.1016/j.jcmgh.2015.01.007. eCollection 2015 Mar.
2
Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies.肠-肝轴与非酒精性脂肪性肝病纤维化：新型治疗方法的切入点。
Dig Liver Dis. 2013 Jul;45(7):543-51. doi: 10.1016/j.dld.2012.11.010. Epub 2012 Dec 29.
3
Obesity and NAFLD: the role of bacteria and microbiota.肥胖与非酒精性脂肪性肝病：细菌和微生物组的作用。
Clin Liver Dis. 2014 Feb;18(1):59-71. doi: 10.1016/j.cld.2013.09.002. Epub 2013 Oct 24.
4
Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?非酒精性脂肪性肝病：是好是坏，归咎于肠道微生物群？
JPEN J Parenter Enteral Nutr. 2013 Nov;37(6):787-93. doi: 10.1177/0148607113481623. Epub 2013 Mar 28.
5
Obesity, fatty liver disease and intestinal microbiota.肥胖、脂肪肝疾病与肠道微生物群
World J Gastroenterol. 2014 Nov 28;20(44):16452-63. doi: 10.3748/wjg.v20.i44.16452.
6
The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation.非酒精性脂肪性肝病的肠道微生物群：当前方法及其解读
Hepatol Int. 2015 Jul;9(3):406-15. doi: 10.1007/s12072-015-9640-2. Epub 2015 Jun 12.
7
Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis.非酒精性脂肪性肝病、非酒精性脂肪性肝炎和肝硬化中的益生菌
J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1:S28-32. doi: 10.1097/MCG.0000000000000347.
8
The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease.肠道细菌过度生长在肥胖相关非酒精性脂肪性肝病中的作用。
Nutrients. 2014 Dec 3;6(12):5583-99. doi: 10.3390/nu6125583.
9
Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.肠-肝轴与益生菌：它们在非酒精性脂肪性肝病中的作用
World J Gastroenterol. 2014 Nov 14;20(42):15518-31. doi: 10.3748/wjg.v20.i42.15518.
10
Gut microbiota and host metabolism in liver cirrhosis.肝硬化中的肠道微生物群与宿主代谢
World J Gastroenterol. 2015 Nov 7;21(41):11597-608. doi: 10.3748/wjg.v21.i41.11597.
引用本文的文献
1
The Metabolic Response to a Low Amino Acid Diet is Independent of Diet-Induced Shifts in the Composition of the Gut Microbiome.低氨基酸饮食引起的代谢反应独立于饮食诱导的肠道微生物组组成变化。
Sci Rep. 2019 Jan 11;9(1):67. doi: 10.1038/s41598-018-37177-3.
2
Colon Epithelial MicroRNA Network in Fatty Liver.脂肪性肝病中结肠上皮细胞的 microRNA 网络
Can J Gastroenterol Hepatol. 2018 Sep 24;2018:8246103. doi: 10.1155/2018/8246103. eCollection 2018.
本文引用的文献
1
Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability.非酒精性脂肪性肝炎中的肝损伤导致肠道通透性改变。
Cell Mol Gastroenterol Hepatol. 2015 Mar;1(2):222-232. doi: 10.1016/j.jcmgh.2015.01.001.
2
Intestinal permeability in non-alcoholic fatty liver disease: the gut-liver axis.非酒精性脂肪性肝病中的肠道通透性：肠-肝轴
Rev Recent Clin Trials. 2014;9(3):141-7. doi: 10.2174/1574887109666141216104334.
3
The global NAFLD epidemic.全球非酒精性脂肪性肝病流行状况。
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):686-90. doi: 10.1038/nrgastro.2013.171. Epub 2013 Sep 17.
4
Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease.非酒精性脂肪性肝病肥胖患者的粪便微生物组和挥发性有机化合物代谢组。
Clin Gastroenterol Hepatol. 2013 Jul;11(7):868-75.e1-3. doi: 10.1016/j.cgh.2013.02.015. Epub 2013 Feb 27.
5
Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.循环肠通透素，一种肠通透性的标志物，与肥胖相关的胰岛素抵抗有关。
PLoS One. 2012;7(5):e37160. doi: 10.1371/journal.pone.0037160. Epub 2012 May 18.
6
Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease.肠-肝轴：肠道微生物群对非酒精性脂肪性肝病的影响。
Nutr Metab Cardiovasc Dis. 2012 Jun;22(6):471-6. doi: 10.1016/j.numecd.2012.02.007. Epub 2012 Apr 28.
7
Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice.饮食诱导肥胖小鼠的肠道通透性增加和微生物群改变与肠系膜脂肪炎症和代谢功能障碍有关。
PLoS One. 2012;7(3):e34233. doi: 10.1371/journal.pone.0034233. Epub 2012 Mar 23.
8
DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH.DSS 诱导的结肠炎增加门脉 LPS 水平，并增强实验性 NASH 中的肝炎症和肝纤维化。
J Hepatol. 2011 Dec;55(6):1391-9. doi: 10.1016/j.jhep.2011.02.035. Epub 2011 Apr 13.
9
The role of the gut microbiota in nonalcoholic fatty liver disease.肠道微生物群在非酒精性脂肪性肝病中的作用。
Nat Rev Gastroenterol Hepatol. 2010 Dec;7(12):691-701. doi: 10.1038/nrgastro.2010.172. Epub 2010 Nov 2.
10
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中肠道通透性增加和紧密连接改变
Hepatology. 2009 Jun;49(6):1877-87. doi: 10.1002/hep.22848.
Zotero 插件